"Toxic debate" over treatment for gender dysphoria in UK leaves judges without expert medical witnesses
BMJ
.
2024 May 9:385:q1057.
doi: 10.1136/bmj.q1057.
Author
Clare Dyer
1
Affiliation
1
The BMJ.
PMID:
38724094
DOI:
10.1136/bmj.q1057
No abstract available
Publication types
News
MeSH terms
Expert Testimony
Female
Gender Dysphoria* / drug therapy
Humans
Male
United Kingdom